This ambitious plan includes many initiatives across economic development, visitor engagement, regional partnerships, public policy, talent and education, industry sectors, community issues and more.
The U.S. Department of Commerce's "Build to Scale" program is designed to support technology entrepreneurs, foster innovation and drive economic growth.
This international collaboration marks a significant step forward in the quest to overcome some of the hurdles faced by scientists in the production of complex molecules needed for lifesaving medicines.
The Greater Oklahoma City’s biosciences cluster has made significant progress over the last two decades to become one of the region’s growth sectors, employing about 31,000 people and spending $316 million annually on research and development.
The president and chief executive officer of Oklahoma City’s thriving Innovation District has stepped down and current board member Cathy O’Connor was named interim president and CEO.
The Oklahoma Medical Research Foundation recently introduced a new DNA sequencer that will help accelerate research on everything from Alzheimer’s disease to cancer.
Connections made at the Biotechnology Innovation Organization’s (BIO) annual convention could spark a new wave of industry growth in Oklahoma City. A contingent of more than 40 people from Oklahoma’s bioscience and life sciences community attended the convention in Boston last month. BIO 2023 attracted almost 20,000 people engaged in bioscience-related work.
Chamber executives, entrepreneurs and local officials are preparing to attend two large conferences and pitch Oklahoma City as a premier destination for biotechnology and retail.
